Tumor growth or regression: powered by inflammation.

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Malignant cells exist within a specialized tumor microenvironment containing stromal cells, blood vessels, and leukocytes.
• Intratumoral inflammation often promotes tumor angiogenesis and creates an immunosuppressive milieu, hindering anti-cancer immunity.
• This pro-angiogenic inflammatory loop is a significant barrier to effective adaptive anti-cancer immune responses.

Purpose of the Study:

• To propose a novel concept integrating anti-angiogenic and immune therapeutic strategies.
• To explore the potential of reversing pro-angiogenic inflammation to facilitate anti-cancer immune responses.
• To investigate how modulating the tumor inflammatory context can enhance immune-mediated tumor destruction.

Main Methods:

• Conceptual integration of existing evidence on tumor microenvironment, inflammation, and angiogenesis.
• Analysis of the dynamic nature of angiogenesis in response to inflammatory contexts.
• Theoretical framework for shifting inflammation from pro-angiogenic to anti-angiogenic.

Main Results:

• Pro-angiogenic inflammation fosters tumor growth and immunosuppression.
• Angiogenesis is a dynamic process that can be reversed.
• A shift to anti-angiogenic inflammation can create a tumor environment conducive to immune-mediated destruction.

Conclusions:

• Modulating the tumor microenvironment's inflammatory state is crucial for effective cancer therapy.
• Shifting from pro-angiogenic to anti-angiogenic inflammation can overcome immune suppression.
• This paradigm integrates anti-angiogenic therapies with immune treatments for enhanced anti-cancer efficacy.